Bosentan in Children With Pulmonary Arterial Hypertension

Mise à jour : Il y a 5 ans
Référence : NCT00319267

Femme et Homme

Extrait

The aim of the study is to demonstrate that the exposure to bosentan in children with idiopathic pulmonary arterial hypertension (PAH) or familial pulmonary arterial hypertension, using a pediatric formulation, is similar to that in adults with PAH and to evaluate the tolerability and safety of a pediatric formulation of bosentan in this patient population.


Critère d'inclusion

  • pulmonary arterial hypertension


Liens